<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6881455</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31824400</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6881455</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fneur.2019.01217</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Summary of PD patients' demographic information in the current study.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Summary of PD patients' demographic information in the current study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Group</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>ID</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Age</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Sex</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>PD duration (years)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>MoCA</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>LID duration (years)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>BDI</bold></th><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;" rowspan="1"><bold>MDS-UPDRS-III</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>AIMS</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Anti-PD medications</bold></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>OFF</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>ON</bold></th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">LID</td><td valign="top" align="left" rowspan="1" colspan="1">PD02</td><td valign="top" align="center" rowspan="1" colspan="1">76</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">2.5</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">LD. Amantadine</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD03</td><td valign="top" align="center" rowspan="1" colspan="1">66</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">1.25</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">LD. DA</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD05</td><td valign="top" align="center" rowspan="1" colspan="1">73</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">52</td><td valign="top" align="center" rowspan="1" colspan="1">43</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">LD. Amantadine</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD09</td><td valign="top" align="center" rowspan="1" colspan="1">55</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">1.5</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">37</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">LD.</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD10</td><td valign="top" align="center" rowspan="1" colspan="1">65</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">37</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">LD. Amantadine</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Non-LID</td><td valign="top" align="left" rowspan="1" colspan="1">PD01</td><td valign="top" align="center" rowspan="1" colspan="1">55</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">LD. Amantadine</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD04</td><td valign="top" align="center" rowspan="1" colspan="1">71</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">LD. DA.MOA-B.</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD06</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">53</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">LD.</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD07</td><td valign="top" align="center" rowspan="1" colspan="1">68</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">LD.</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">PD08</td><td valign="top" align="center" rowspan="1" colspan="1">77</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">LD.MOA-B</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>P</italic>-value</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.0</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.22</td><td valign="top" align="center" rowspan="1" colspan="1">0.07</td><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.13</td><td valign="top" align="center" rowspan="1" colspan="1">0.32</td><td valign="top" align="center" rowspan="1" colspan="1">0.49</td><td valign="top" align="center" rowspan="1" colspan="1">0.004</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>PD, Parkinson's disease; MoCA, Montreal cognitive assessment test; MDS-UPDRS, movement disorder society—unified Parkinson's disease rating scale; AIMS, abnormal involuntary movement scale; LD, Levodopa; DA, dopamine agonist; MOA-B, Monoamine oxidase B inhibitors; M, male; F, female</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of PD patients' demographic information in the current study.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Group</th><th valign="top" align="left">ID</th><th valign="top" align="center">Age</th><th valign="top" align="left">Sex</th><th valign="top" align="center">PD duration (years)</th><th valign="top" align="center">MoCA</th><th valign="top" align="center">LID duration (years)</th><th valign="top" align="center">BDI</th><th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;">MDS-UPDRS-III</th><th valign="top" align="center">AIMS</th><th valign="top" align="center">Anti-PD medications</th></tr><tr><th/><th/><th/><th/><th/><th/><th/><th/><th valign="top" align="center">OFF</th><th valign="top" align="center">ON</th><th/><th/></tr></thead><tbody><tr><td valign="top" align="left">LID</td><td valign="top" align="left">PD02</td><td valign="top" align="center">76</td><td valign="top" align="left">M</td><td valign="top" align="center">6</td><td valign="top" align="center">22</td><td valign="top" align="center">2.5</td><td valign="top" align="center">12</td><td valign="top" align="center">31</td><td valign="top" align="center">19</td><td valign="top" align="center">2</td><td valign="top" align="left">LD. Amantadine</td></tr><tr><td/><td valign="top" align="left">PD03</td><td valign="top" align="center">66</td><td valign="top" align="left">M</td><td valign="top" align="center">11</td><td valign="top" align="center">23</td><td valign="top" align="center">1.25</td><td valign="top" align="center">6</td><td valign="top" align="center">20</td><td valign="top" align="center">10</td><td valign="top" align="center">1</td><td valign="top" align="left">LD. DA</td></tr><tr><td/><td valign="top" align="left">PD05</td><td valign="top" align="center">73</td><td valign="top" align="left">M</td><td valign="top" align="center">18</td><td valign="top" align="center">21</td><td valign="top" align="center">6</td><td valign="top" align="center">9</td><td valign="top" align="center">52</td><td valign="top" align="center">43</td><td valign="top" align="center">3</td><td valign="top" align="left">LD. Amantadine</td></tr><tr><td/><td valign="top" align="left">PD09</td><td valign="top" align="center">55</td><td valign="top" align="left">M</td><td valign="top" align="center">5</td><td valign="top" align="center">24</td><td valign="top" align="center">1.5</td><td valign="top" align="center">6</td><td valign="top" align="center">37</td><td valign="top" align="center">30</td><td valign="top" align="center">2</td><td valign="top" align="left">LD.</td></tr><tr><td/><td valign="top" align="left">PD10</td><td valign="top" align="center">65</td><td valign="top" align="left">F</td><td valign="top" align="center">14</td><td valign="top" align="center">29</td><td valign="top" align="center">8</td><td valign="top" align="center">10</td><td valign="top" align="center">37</td><td valign="top" align="center">21</td><td valign="top" align="center">3</td><td valign="top" align="left">LD. Amantadine</td></tr><tr><td valign="top" align="left">Non-LID</td><td valign="top" align="left">PD01</td><td valign="top" align="center">55</td><td valign="top" align="left">M</td><td valign="top" align="center">5</td><td valign="top" align="center">30</td><td/><td valign="top" align="center">0</td><td valign="top" align="center">19</td><td valign="top" align="center">9</td><td valign="top" align="center">0</td><td valign="top" align="left">LD. Amantadine</td></tr><tr><td/><td valign="top" align="left">PD04</td><td valign="top" align="center">71</td><td valign="top" align="left">M</td><td valign="top" align="center">7</td><td valign="top" align="center">29</td><td/><td valign="top" align="center">4</td><td valign="top" align="center">31</td><td valign="top" align="center">30</td><td valign="top" align="center">0</td><td valign="top" align="left">LD. DA.MOA-B.</td></tr><tr><td/><td valign="top" align="left">PD06</td><td valign="top" align="center">64</td><td valign="top" align="left">M</td><td valign="top" align="center">4</td><td valign="top" align="center">23</td><td/><td valign="top" align="center">5</td><td valign="top" align="center">53</td><td valign="top" align="center">14</td><td valign="top" align="center">0</td><td valign="top" align="left">LD.</td></tr><tr><td/><td valign="top" align="left">PD07</td><td valign="top" align="center">68</td><td valign="top" align="left">M</td><td valign="top" align="center">8</td><td valign="top" align="center">27</td><td/><td valign="top" align="center">8</td><td valign="top" align="center">22</td><td valign="top" align="center">16</td><td valign="top" align="center">0</td><td valign="top" align="left">LD.</td></tr><tr><td/><td valign="top" align="left">PD08</td><td valign="top" align="center">77</td><td valign="top" align="left">F</td><td valign="top" align="center">10</td><td valign="top" align="center">29</td><td/><td valign="top" align="center">4</td><td valign="top" align="center">24</td><td valign="top" align="center">23</td><td valign="top" align="center">0</td><td valign="top" align="left">LD.MOA-B</td></tr><tr><td valign="top" align="left">P-value</td><td/><td valign="top" align="center">1.0</td><td/><td valign="top" align="center">0.22</td><td valign="top" align="center">0.07</td><td/><td valign="top" align="center">0.13</td><td valign="top" align="center">0.32</td><td valign="top" align="center">0.49</td><td valign="top" align="center">0.004</td><td/></tr></tbody></table></div>PD, Parkinson's disease; MoCA, Montreal cognitive assessment test; MDS-UPDRS, movement disorder society—unified Parkinson's disease rating scale; AIMS, abnormal involuntary movement scale; LD, Levodopa; DA, dopamine agonist; MOA-B, Monoamine oxidase B inhibitors; M, male; F, female.</transformed-table></extracted-table></extracted-tables-set>